Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update.
Outbreaks and sporadic cases of hepatitis A have been observed in 4 European countries in hemophilia patients receiving factor VIII preparations. PCR amplification of potential hepatitis A virus (HAV) nucleic acid present in plasma pools, purified factor VIII and acute-phase sera from infected individuals has been performed and the nucleic acid sequence determined for those samples that resulted in a positive PCR product. HAV sequences were detected in the serum of 2 German patients, but not in the factor VIII lots administered to these individuals. Screening of plasma pools and the corresponding 5 lots of factor VIII associated with the outbreak in Ireland did not reveal any HAV sequences. In contrast, a study of samples from Italy detected HAV sequences in 5 of 12 lots and in 2 hemophilia patients who developed hepatitis A. These data suggest that implicated factor VIII preparations might have been involved in the outbreaks of HAV infection among Italian hemophiliacs. However, no molecular evidence was obtained for a similar association in Germany or Ireland. The preliminary data from these two investigations must be verified by animal inoculation studies and supported by epidemiologic analysis.
Robertson
B H
BH
Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333.
Friedberg
D
D
Normann
A
A
Graff
J
J
Flehmig
B
B
Shouval
D
D
D001483:Base Sequence; D016913:Blood Component Transfusion / Q000009:adverse effects*; D005060:Europe; D005169:Factor VIII / Q000009:adverse effects*; D005838:Genotype; D006467:Hemophilia A / Q000628:therapy*; D006506:Hepatitis A / Q000382:microbiology* / Q000635:transmission; D006507:Hepatovirus / Q000235:genetics*; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data
D005169:Factor VIII